MedTech Forum 2018

Aquarius Population Health is excited to participate in the 2018 MedTech Forum in Brussels on the 23-25th January. The MedTech Forum is one of the largest health and medical technology industry conferences in Europe. Since 2007, it provides participants with the chance to gather insights on the latest industry trends, as well as networking opportunities with other business leaders, leading innovators and investors. The MTF 2018 programme will focus on digital developments, new business strategies and innovation.

At this year’s Forum, Aquarius will be exhibiting along with other innovative MedTech companies and partners. Stop by our stand and have a chat with the team –Elisabeth, Susie and Mike will be on hand to hear about your challenges and come up with creative solutions. We will also be showcasing our interactive decision tools and will have live demos to try out.

We hope to see you there! And if you can’t make it, but still want to see the demo tools, get in touch to set up a meeting.

Antimicrobial Resistance

Safeguarding our future through better antimicrobial stewardship.

Antimicrobial resistance (AMR) is a growing concern on a global scale. Without swift action, antimicrobial resistance will mean that some infections become untreatable. New technologies – including rapid diagnostics and new antimicrobials – have the potential to slow down or prevent the spread of AMR. At Aquarius Population Health, we have worked on numerous AMR projects with a range of organisations. Projects have evaluated the costs, benefits and impact of using AMR technologies to detect drug resistance and optimise antibiotic prescribing including using new therapeutics.

Read more

Rapid Diagnostics

Faster answers for better outcomes

Rapid diagnostics are revolutionising the way that clinical decisions are made. Rapid diagnostic technology can yield better results for patients, healthcare providers, and the wider population when introduced in the right way. We can help you understand the options for implementing rapid diagnostics into current care pathways, and can quantify the costs, benefits and impact. This gives you the evidence to support better healthcare delivery.

Read more


Optimising cancer pathways

Pathways for the diagnosis, treatment and follow-up of patients with cancer are complex. Cancer care information is held in different sites, making a holistic view to care challenging. We visualise the different routes to diagnosis and treatment, and quantify the burden to the healthcare system.  This provides a more complete understanding of the opportunities for introducing innovation and improvement into cancer care resulting in better outcomes for patients and more efficient services.

Read more